Related Experiment Video
Updated: May 12, 2025
One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles
Published on: September 17, 2013
Small Molecule-Mediated Photothermal Therapy Induces Apoptosis in Cancer Cells
Asima Sahu1, Jaypalsing Ingle1, Reha Panigrahi1
1Department of Chemistry, Indian Institute of Technology Gandhinagar, Palaj Gandhinagar, 382355, India.
Abstract:
Cancer remains as one of the most life-threatening diseases in the whole world. Most of the therapeutic strategies to eradicate cancer are highly invasive, leading to severe injury and trauma to the patients. In recent times, phototherapy has emerged as one of the noninvasive therapeutic strategies for cancer treatment. However, development of novel small-molecule photothermal agents remains a major challenge. To address this, herein, a small molecule library having aromatic substituted-3-methoxy-pyrrole and 2-(3-cyano-4,5,5-trimethylfuran-2(5 H)-ylidene) malononitrile in a concise synthetic strategy is designed and synthesized. One of the library members (7H) self-assembles into spherical-like nanoparticles having <100 nm size in water and is found to exhibit remarkable increase in temperature under 740 nm near-infrared (NIR) light. Interestingly, compound 7H homes into the lysosomal compartments and the lipid droplets in the HCT-116 colon cancer cells within 3 h and induces photothermal effect followed by generation of reactive oxygen species while irradiating under 740 nm NIR light for 10 min. Moreover, 7H triggers programmed cell death (apoptosis) to induce remarkable HCT-116 cell killing. This small molecule-mediated photothermal effect shows potential to be an interesting tool for the next-generation noninvasive cancer phototherapy.
Insights
Researchers developed a novel small molecule that forms nanoparticles for noninvasive cancer phototherapy. This agent effectively kills colon cancer cells using near-infrared light, offering a promising new treatment strategy.
Area of Science:
- Nanotechnology
- Photomedicine
- Organic Chemistry
Background:
- Cancer therapies often involve invasive procedures causing significant patient trauma.
- Phototherapy offers a noninvasive alternative, but novel photothermal agents are needed.
- Developing small-molecule photothermal agents is a key challenge in cancer treatment.
Purpose of the Study:
- To design and synthesize a novel small molecule library for photothermal cancer therapy.
- To evaluate the photothermal properties and cancer-killing efficacy of a lead compound (7H).
- To explore the potential of small molecule-mediated photothermal therapy for noninvasive cancer treatment.
Main Methods:
- Synthesis of a small molecule library containing substituted pyrrole and furan derivatives.
- Characterization of self-assembly into nanoparticles and temperature increase under near-infrared (NIR) light.
- In vitro evaluation of compound 7H's cellular uptake, photothermal effect, reactive oxygen species generation, and apoptosis induction in HCT-116 colon cancer cells.
Main Results:
- A library member (7H) self-assembles into <100 nm nanoparticles in water.
- Compound 7H exhibits significant temperature increase under 740 nm NIR light.
- 7H targets colon cancer cells, inducing photothermal effects, reactive oxygen species generation, and apoptosis, leading to significant cell death.
Conclusions:
- A novel small molecule (7H) acts as an effective photothermal agent for cancer therapy.
- The compound demonstrates efficient cancer cell targeting and destruction via photothermal and reactive oxygen species-mediated mechanisms.
- This small molecule-based approach shows potential for next-generation noninvasive cancer phototherapy.
Related Concept Videos
01:31The Intrinsic Apoptotic Pathway
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Tumor Immunotherapy
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...